On August 13, York Space Systems (NYSE:YSS) walked investors through a quarter that looked strong on execution but weak on near-term revenue. The satellite maker put 21 more spacecraft into orbit, closed two acquisitions, and kept winning new government work. Yet management also trimmed full-year 2026 revenue guidance by $180 million at the midpoint, pointing to supply chain delays and a shift in how the government is now buying space hardware. The mixed signals leave a real question for shareholders: is this a timing hiccup or something more persistent?
Winning Faster Than It Can Bill
York’s order book tells a growing-demand story even as the income statement lags behind it. Backlog reached $592 million as of June 30, up 9% since the start of the year on new commercial contract wins and a contract modification. Layer on $1.85 billion in potential unawarded contracts and an identified pipeline of $11.5 billion across 12 potential customers, and the demand pool dwarfs current sales. York backed that pipeline with results, winning eight of the contracts it bid on in the first half of 2026, an 88% win rate spanning 10 different mission areas.
The government’s move toward Indefinite Delivery, Indefinite Quantity contracts sits behind much of that pipeline. These IDIQ vehicles take longer to award initially, but once in place they let the government issue task orders without another competitive round. York already turned three new national security IDIQ awards into two delivery orders, an early sign that the faster back half of that cycle is starting to play out. On the hardware side, York became the first Tranche 1 Transport Layer awardee to finish its full commitment, putting its last 21 satellites into orbit via a dedicated Falcon 9 launch for a 42-for-42 record and pushing its total constellation to 55 satellites. The acquisitions of ALL.SPACE and Solestial extend that platform into assured communications terminals and domestic solar cell production, with subsidiaries expected to supply 10% to 15% of 2026 revenue.
The Revenue Calendar Ate
The same contracting shift that built York’s pipeline is also why the company just cut its own guidance. Management lowered full-year 2026 revenue guidance to a range of $375 million to $405 million, a $180 million reduction at the midpoint from the prior $570 million target, as new business that can’t be booked this year and ongoing supply chain delays pushed work into 2027. Chief Accounting Officer and Interim CFO Brian Frantz said the cut would also weigh on adjusted EBITDA in the second half. That loss already widened slightly in the second quarter, to $9.5 million from $8.9 million a year earlier, even as gross margin and contribution margin both improved.
The gap came from operating expenses: SG&A and R&D spending rose 52% year over year on higher headcount, public company infrastructure costs, and the integration of recent acquisitions. Backlog also slipped 8% during the quarter itself, from $642 million at the end of the first quarter to $592 million at the end of the second, even though it sits higher than where the year started. And the company just spent $155 million in cash on ALL.SPACE alone, adding integration work on top of a business that is still unprofitable on an adjusted EBITDA basis.
What The Trading Desks See
Hedge fund ownership of York fell from 34 funds to 23 in the most recent quarter, a pullback that suggests some institutional holders are trimming rather than adding. Short interest sits at 7.84% of the float, a level that points to a real but not overwhelming bear camp rather than a heavily crowded short. That combination suggests the guidance cut has cost York some conviction without yet triggering an aggressive bet against it.
Where The Next Year Lands
York now has more contracted demand than it can currently turn into revenue, and a narrower window to close that gap before investors lose patience. The IDIQ task orders already in hand need to convert into 2027 revenue on the timeline management now expects, and the newly acquired subsidiaries need to add revenue without adding further losses. Supply chain delays and a rising cost base are the counterweight, and another guidance cut would be harder to explain away than this one.
READ NEXT: 10 Best Future Stocks to Buy Under $10 and 12 Best Performing Semiconductor Stocks to Invest In.
Disclosure: None. Follow Insider Monkey on Google News.
